Latest Earnings Results: Q4 '26
Estimated EPS
-$0.39
Reported EPS
-$0.32
Surprise
+17.33%
Estimated Rev
$123.55M
Reported Rev
$126.64M
Surprise
+2.51%
• Reported GAAP EPS of -$0.32 up 28.89% YoY • Reported revenue of $126.64M up 27.91% YoY • Twist Bioscience expects Fiscal 2027 revenue of approximately $550M to $560M, gross margin of approximately 52.5% to 53%, and positive adjusted EBITDA; Q1 FY2027 revenue guidance is $130M to $132M.
Generated by Stocktwits using AI and company-reported earnings data for Q4 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q1 '27 | -$0.36 | -- | -- | N/A |
Q4 '26 | -$0.39 | -$0.32 | 17.33% | BEAT |
Q3 '26 | -$0.49 | -$0.56 | -13.51% | MISSED |
Q2 '26 | -$0.48 | -$0.71 | -48.72% | MISSED |
Q1 '26 | -$0.42 | -$0.50 | -17.92% | MISSED |